The invention relates to compounds of structural formula (I) and structuralformula (Vl): or a pharmaceutically acceptable salt, solvate, clathrate, orprodrug thereof, wherein R, R1, R2, Z, L, and n are defined herein. Thesecompounds are useful as immunosuppressive agents and for treating andpreventing inflammatory conditions, allergic disorders, and immune disorders.